ZLAB Q3 2025 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$116M+13.5% YoY

Gross Profit

$69M59.6% margin

Operating Income

-$49M-42.1% margin

Net Income

-$36M-31.0% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+5.6%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$36M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$399M

Stockholders' Equity

$760M

Cash & Equivalents

$717M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$116M	$102M	+13.5%
Gross Profit	$69M	$65M	+5.9%
Operating Income	-$49M	-$68M	+28.0%
Net Income	-$36M	-$42M	+13.7%

Revenue Segments

Zejula

$42M53%

Nuzyra

$15M19%

Optune

$13M16%

Qinlock

$9M11%

Product and Service, Other

$92,0000%